Document is current

Any future updates will be listed below

Correction to: Prognostic value of total metabolic tumour volume and therapy-response assessment by [18F]FDG PET/CT in patients with metastatic melanoma treated with BRAF/MEK inhibitors

Crossref DOI link: https://doi.org/10.1007/s00330-022-08672-z

Published Online: 2022-03-09

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark